Recent Alzheimer's Studies
The field of Alzheimers studies is a critical area used by doctors in the search for a definitive cure of Alzheimer’s disease. This field is characterized by clinical trials that focus on two important areas about Alzheimer’s disease: the study of the progression and development of the illness in diagnosed individuals, and the search for potential methods that can be used to halt or slow down the advance of, if not fully cure, the disease.
Over the last 10 years, significant strides have been made in understanding the nature of Alzheimer’s as an illness. This is made possible by advancements in medical technology that have helped to observe, see and peer into the brain as the illness mercilessly advances. Consequently, the understanding of the nature of the disease has led to interesting hypotheses on what can be done to arrest it or maybe even prevent it in the future.
To put these hypotheses to the test, Alzheimers studies advance the use of clinical research to determine how patients react to various factors in their environment. Today, an estimated 50,000 Alzheimer’s patients have volunteered to take part in these Alzheimers studies, armed with the determination to prevent the progress of the disease at all cost. In the United States alone, there are an estimated 180 active studies and trials that are being done to drive the goal of treatment forward.
To understand how this research intends to achieve its goal, we will look at a brief explanation of how these studies and trials are defined.
· Clinical Studies. These are primarily focused on observation and data collection from patients diagnosed with the disease. Currently, neuro-imaging and genetic studies are at the forefront of Alzheimers studies and these serve to determine the underlying causal links that should eventually elucidate the real reason for the onset of the illness.
· Clinical Trials. These, on the other hand, are more active methods of engaging diagnosed patients. Typical activities include trials of new drugs or the use of methods or devices aimed at seeing how the disease reacts to the new stimuli. Of course, all clinical trials have prior approval by the Food and Drug Administration to ascertain that they are safe and would not cause any harm to the patient. These clinical trials are a direct offshoot of the data collected from Alzheimers studies.
Because of the sheer scale of the number of volunteers required to make the clinical studies and trials meaningful, Alzheimer’s disease Centers welcome the participation of diagnosed patients in these Alzheimers studies and clinical trials. Adequate explanation of the nature of the forthcoming activities regarding the patient and family members alike are gone over to establish the expectations of those participating in the studies.
The rapid progress of Alzheimer’s disease based on statistics requires a swift and targeted response that is designed to tackle the issues in a more aggressive manner. For this reason, Alzheimers studies and clinical trials are important now than ever before. In them lies our best chance of finding a cure or slowing down the disease’s progress. Everyone is enjoined to lend a helping hand in the combat against Alzheimer’s disease so we can be spared, patient and loved one alike, from the gripping and life-demeaning effects of Alzheimer’s disease.
Our website have a large volume of information on Alzheimer's disease and Alzheimer's studies so if you have an interest in the subject you may want to bookmark us. We do try and stay updated.